These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Etiology of schizophrenia: neurochemical aspects]. de las Cuevas Castresana C; González de Rivera JL Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627 [No Abstract] [Full Text] [Related]
5. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties]. Arushanian EB Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251 [No Abstract] [Full Text] [Related]
6. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia]. Lideman RR; Zlobina GP; Mukhin AG Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337 [No Abstract] [Full Text] [Related]
7. Integrating the neurobiology of schizophrenia. Preface. Abi-Dargham A; Guillin O Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855 [No Abstract] [Full Text] [Related]
9. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review. Fredrickson P; Richelson E J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063 [TBL] [Abstract][Full Text] [Related]
10. [A biochemical theory of schizophrenia]. Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein M; Deutch AY FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713 [TBL] [Abstract][Full Text] [Related]
12. [The metabolically disordered neuron]. Woelk H Med Klin; 1979 Oct; Suppl():6-9. PubMed ID: 44343 [No Abstract] [Full Text] [Related]
13. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732 [No Abstract] [Full Text] [Related]
14. Atypical antipsychotics. Holland D; Watanabe MD; Sharma R Psychiatr Med; 1991; 9(1):5-24. PubMed ID: 1673259 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance. Wiesel FA Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drugs, neurotransmitters, and schizophrenia. Carlsson A Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684 [TBL] [Abstract][Full Text] [Related]
18. Schizophrenia: diverse approaches to a complex disease. Sawa A; Snyder SH Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological basis of therapeutics: dopamine receptors. Heikkila RE J Med Soc N J; 1984 Dec; 81(12):1084-6. PubMed ID: 6150999 [No Abstract] [Full Text] [Related]
20. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Strange PG Pharmacol Rev; 2001 Mar; 53(1):119-33. PubMed ID: 11171942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]